We appreciate you taking the time out of your busy schedules to attend our Investors Meeting for FY 2025 financial results, management priorities and business strategies. Today's session will begin ...
The oligonucleotides clinical trial analysis report delivers important insights into ongoing research on 600+ ...
Massive volumes of digital data are generated every day from AI training, big data analytics and smart devices. As ...